SensiTox C. difficile Toxin Test
Reagents, Clostridium Difficile Toxin. 510(k) K193490, from First Light Diagnostics, Inc. (Chelmsford, MA). Product code LLH, class 1.
As of Nov 20, 2026, K193490 is an FDA 510(k) held by First Light Diagnostics, Inc., substantially equivalent on Jul 8, 2021 after 569 days, with no recalls tied to it in FDA's recall database.
- Review time: 569 days
- Recalls: 0
The SensiTox C. difficile Toxin Test is an immunofluorescence assay intended for the qualitative detection of Clostridioides difficile toxins A and/or B in human stool specimens. The test is intended as an aid in the diagnosis of C. difficile infection (CDI) in patients exhibiting symptoms of CDI. Negative results do not preclude toxigenic C. difficile infection. The SensiTox C.
- Immunocard Toxins A & B, Model 712050K041003 · Meridian Bioscience, Inc. · Aug 20, 2004
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 17, 2019
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.2660
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files